Live Webcasts


Clinical Trial Design & Analysis to Improve Assay Sensitivity

Live Webinar: Wednesday, October 28, 2015 at 11am ET

Neuroscience studies are prone to high placebo effect, lending themselves well to alternative designs. Learn from PPD experts on how Trimentum™, or sequential parallel comparison design (SPCD), an alternative model for conducting clinical trials, compares and contrasts with other study design methodologies.

Register Free: www.appliedclinicaltrialsonline.com/act/NeuroStudies

Sponsored by: PPD



Clinical Endpoint Adjudication Strategies to Improve CEC Process Flow and Accurate Endpoint Review

Recorded Date: September 22, 2015

In this webcast, experts will explain how to run a successful clinical endpoint committee (CEC), as well as how to mitigate risks to adjudication and put the best processes in place to save time and costs.

Register free: www.appliedclinicaltrialsonline.com/act/CECprocess

Sponsored by: Chiltern


The Impact of Risk-Based Monitoring on Site Performance

Recorded Date: September 16, 2015

Listen to risk-based monitoring experts and a leading Clinical Site discuss how RBM processes are engaging deeper site engagement while mitigating risk and improving patient safety.

Register free at: www.appliedclinicaltrialsonline.com/act/impact

Sponsored by: Quintiles


Using Predictive and Advanced Analytics to Enhance Risk-Based Monitoring

Recorded Date: September 3, 2015

Listen to risk-based monitoring experts highlight new capabilities further mitigating risk and improving patient safety using Predictive and Advanced Analytics.

Register free at: www.appliedclinicaltrialsonline.com/act/dte

Sponsored by: Quintiles


Veeva 2015 Paperless TMF Survey: Annual Report

Recorded Date: July 21, 2015

Hear results from the industry-wide Veeva 2015 Paperless TMF Survey. This annual survey analyzes the observations of TMF owners from around the globe to identify the barriers, business drivers, and benefits of moving to fully paperless TMFs.

Register free at: www.appliedclinicaltrialsonline.com/act/paperless

Sponsored by: Veeva


Embracing a Mobile Medical App in a Clinical Development Strategy to Improve Clinical Outcomes, Increase ROI and Lower Costs

Recorded Date: June 25, 2015

Dedicated patient monitoring devices as well as smartphones, tablets and other wireless devices are rapidly becoming part of modern clinical development strategies. In this presentation, you’ll learn about the benefits of mobile medical applications in clinical trials as well as their implementation challenges. 

Register free at: www.appliedclinicaltrialsonline.com/act/medicalapp

Sponsored by: Theorem Clinical Research



Benefits of Integrating Lab Data into Risk-based Monitoring Execution

Recorded Date: June 23, 2015 

Listen to risk-based monitoring experts explain the benefits of integrated lab data into your monitoring strategy.

Register free at: www.appliedclinicaltrialsonline.com/act/labdata

Sponsored by: Quintiles


eSource--Easier than you Think

Recorded Date: June 11, 2015 

This webinar will provide summary results from a comprehensive survey on eSource conducted by Applied Clinical Trials (in collaboration with OmniComm Systems). The presenters will highlight opportunities for adoption in the light of current regulatory guidance, the exciting confluence of eSource and Risk Based Monitoring initiatives, and specific technical approaches for gathering and managing eSource data. 

Register free at: www.appliedclinicaltrialsonline.com/act/esource

Sponsored by: Omnicomm


Optimize Clinical Trial Results Through Reliable Adherence Measurement

Recorded Date: June 9, 2015

Learn how adherence-informed clinical trials maximize patients’ exposure to the test drugs, simultaneously maximizing drug response and reducing its variance, and thus increasing statistical power. 

Register free at: www.appliedclinicaltrialsonline.com/act/adherence

Sponsored by: WestRock


Reducing the Risk of Phase III Failures

Recorded Date: June 4, 2015 

It is well documented that 50 percent of Late Phase clinical trials fail due to efficacy and/or safety reasons. The result is a tremendous financial burden to biopharmaceutical companies, the engagement of tens of thousands of patients participating in clinical studies to no avail, and significant time lost for patients looking for viable treatment options in numerous therapeutic areas.

Register free at:www.appliedclinicaltrialsonline.com/act/PhaseIIIRisk

Sponsored by: PAREXEL


Considerations for Formally Validating Software in Laboratories Supporting of CLIA Genomic Assays

Recorded Date: June 3, 2015 

Learn of important challenges and lessons in the CLIA validation of a large genomic oncology-focused assay from Dr. Vic Weigman, Associate Director of Translational Genomics at EA/Quintiles.  

Register free at: www.appliedclinicaltrialsonline.com/act/genomic2

Sponsored by: Quintiles


Demystifying Genomics for Drug Developers

Recorded Date: May 19, 2015 

With the US federal government now backing a Precision Medicine Initiative, genomics, personalized medicines, bioinformatics, and next-generation sequencing have stepped into the spotlight and become new buzzwords for drug developers. But what do all of these terms mean? In this webinar we will explore genomic applications to precision medicine programs and shed light on how genomics is transforming drug development.

Register free at: www.appliedclinicaltrialsonline.com/act/demystifying

Sponsored by: Quintiles


Double Blind: De-Identification and Data Masking

Recorded Date: April 28, 2015

The number of clinical trial data sets available for secondary analysis has been growing steadily over the last year. While encouraging, there is a need to also ensure that this data is properly de-identified. This webinar will set expectations about what is needed in a de-identification solution for clinical trial data, and offer a pragmatic look at emerging standards in this area.

Register free at: www.appliedclinicaltrialsonline.com/act/blind 


Change Investigative Site Relationships for the Better

Recorded Date: February 19, 2015

Un-enrolling sites. Slow study start-up. Patient drop out or non-compliance. All of these issues—and more—have been targeted as contributors to high clinical trials costs. But what else do they have in common? They involve principal investigators and site staff. As concern grows, solutions have emerged to help physician researchers better conduct research. Other solutions are aimed to help sponsors identify issues early at the investigative site, to intervene and influence positively when necessary.

Applied Clinical Trials and Partnerships in Clinical Trials join together to bring a group of experts to discuss the importance of the investigator in clinical trials, and how to select and engage them in a true partnership.

Register free at: http://www.appliedclinicaltrialsonline.com/change


Transforming Clinical Operations with a Fully Integrated eTMF Operating Model

Recorded Date: January 28, 2015

Hear how life sciences companies are moving to a purpose-built eTMF application to transform clinical operations for greater access, visibility, and control of clinical studies.

Register free at: www.appliedclinicaltrialsonline.com/operating


Adaptive Design in Early-Phase Oncology Trials – Best Practices for Conduct

Recorded Date: Wednesday, November 12, 2014

Theorem’s Connie Wierman and Jeff Joseph along with Howard Grossberg, MD, and Dr. Sarina Piha-Paul, come together to discuss best practices for implementing adaptive trial designs in early-phase oncology studies for sites, CROs and sponsors.

Register free at: www.appliedclinicaltrialsonline.com/conduct